# Effects of ABT-089 on Smoking Abstinence Symptoms and Reward

> **NCT01756053** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 17 (actual)

## Conditions studied

- Nicotine Addiction

## Interventions

- **DRUG:** ABT-089
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01756053
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Trial discontinued based on the results of an interim futility analysis.
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756053, "Effects of ABT-089 on Smoking Abstinence Symptoms and Reward". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01756053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*